Keywords: USA, Tax, Orphan Drug exclusion, IRS, PPTA, Rare diseases

Orphan drug exclusion from US drug tax stand to harm innovation on rare diseases

Article | 22 August 2011

The US Internal Revenue Services' issuance of temporary and proposed regulations implementing the annual pharmaceutical fee undermines patients with rare ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in